| 1 | find out more about | | | | | | | 9 | 0.84% |
| 2 | out more about this | | | | | | | 8 | 0.75% |
| 3 | more about this service | | | | | | | 8 | 0.75% |
| 4 | out of these cookies | | | | | | | 2 | 0.19% |
| 5 | cookies to improve your | | | | | | | 2 | 0.19% |
| 6 | to improve your experience | | | | | | | 2 | 0.19% |
| 7 | european joint programme on | | | | | | | 2 | 0.19% |
| 8 | uses cookies to improve | | | | | | | 2 | 0.19% |
| 9 | for the website to | | | | | | | 2 | 0.19% |
| 10 | the website to function | | | | | | | 2 | 0.19% |
| 11 | aspects organisational impact social | | | | | | | 1 | 0.09% |
| 12 | their value for patients | | | | | | | 1 | 0.09% |
| 13 | developing complex healthrelated technologies | | | | | | | 1 | 0.09% |
| 14 | complex healthrelated technologies in | | | | | | | 1 | 0.09% |
| 15 | social and legal aspects | | | | | | | 1 | 0.09% |
| 16 | impact social and legal | | | | | | | 1 | 0.09% |
| 17 | healthrelated technologies in order | | | | | | | 1 | 0.09% |
| 18 | technologies in order to | | | | | | | 1 | 0.09% |
| 19 | in order to fully | | | | | | | 1 | 0.09% |
| 20 | understand their value for | | | | | | | 1 | 0.09% |
| 21 | value for patients and | | | | | | | 1 | 0.09% |
| 22 | effectiveness economic sustainability ethical | | | | | | | 1 | 0.09% |
| 23 | for patients and society | | | | | | | 1 | 0.09% |
| 24 | patients and society overall | | | | | | | 1 | 0.09% |
| 25 | the costs and benefits | | | | | | | 1 | 0.09% |
| 26 | organisational impact social and | | | | | | | 1 | 0.09% |
| 27 | and society overall this | | | | | | | 1 | 0.09% |
| 28 | society overall this can | | | | | | | 1 | 0.09% |
| 29 | include safety clinical effectiveness | | | | | | | 1 | 0.09% |
| 30 | safety clinical effectiveness economic | | | | | | | 1 | 0.09% |
| 31 | clinical effectiveness economic sustainability | | | | | | | 1 | 0.09% |
| 32 | costs and benefits of | | | | | | | 1 | 0.09% |
| 33 | skip to content explore | | | | | | | 1 | 0.09% |
| 34 | assess the costs and | | | | | | | 1 | 0.09% |
| 35 | initiated a mentoring programme | | | | | | | 1 | 0.09% |
| 36 | failure rates for this | | | | | | | 1 | 0.09% |
| 37 | rates for this reason | | | | | | | 1 | 0.09% |
| 38 | for this reason the | | | | | | | 1 | 0.09% |
| 39 | this reason the european | | | | | | | 1 | 0.09% |
| 40 | reason the european joint | | | | | | | 1 | 0.09% |